AbClon Inc. (KOSDAQ:174900)
South Korea · Delayed Price · Currency is KRW 30,900
-3,100 (-9.12%)
Aug 12, 2026, 3:30 PM KST
AbClon Market Cap
AbClon has a market cap or net worth of 678.37 billion as of August 12, 2026. Its market cap has increased by 229.90% in one year.
Market Cap
678.37B
Enterprise Value
643.98B
Revenue
4.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
30,900.00
ChartMarket Cap Chart
Since September 18, 2017, AbClon's market cap has increased from 176.80B to 678.37B, an increase of 283.69%. That is a compound annual growth rate of 16.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 678.37B | -16.48% |
| Dec 30, 2025 | 812.27B | 230.14% |
| Dec 30, 2024 | 246.04B | 6.90% |
| Dec 28, 2023 | 230.16B | 17.39% |
| Dec 29, 2022 | 196.07B | -27.49% |
| Dec 30, 2021 | 270.42B | -48.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 1.52T |
| Chabiotech | 899.12B |
| Hyundai Bioscience | 727.64B |
| Pharmicell | 702.05B |
| Onconic Therapeutics | 666.13B |
| GI Innovation | 596.13B |
| Medy-Tox | 527.27B |
| GC Corp. | 482.62B |